Predicting outcomes in malignant ovarian germ cell tumors using the modified International Germ Cell Cancer Collaborative Group classification system

被引:0
|
作者
Zhang, Xinyue [1 ,2 ]
Yang, Jie [1 ,2 ]
Xiang, Yang [1 ]
Wu, Ming [1 ]
Cao, Dongyan [1 ]
Wang, Jinhui [1 ]
Yang, Jiaxin [1 ,2 ]
机构
[1] Peking Union Med Coll Hosp, Obstet & Gynecol, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Beijing, Peoples R China
基金
国家重点研发计划;
关键词
Ovarian Neoplasms; Ovarian Diseases; PROGNOSTIC-FACTORS; CHEMOTHERAPY; MANAGEMENT; SURVIVAL; COHORT;
D O I
10.1136/ijgc-2024-005489
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives The aim of our study was to evaluate the feasibility of the modified International Germ Cell Cancer Collaborative Group risk classification system in Chinese female patients with malignant ovarian germ cell tumors and to identify predictive factors to enhance the risk classification system. Methods In this retrospective cohort analysis, patients with malignant ovarian germ cell tumors who received surgery with/without chemotherapy were included. These patients had been followed-up by Peking Union Medical College Hospital between 2011 to 2020. Patients without complete medical records or no follow-up information were excluded. Results The study enrolled a total of 271 patients. The risk model classified 106 (39.1%) patients as good-, 84 (31%) as intermediate-, and 81 (29.9%) as poor-risk. With a median follow-up time of 34 months (range 2-147), 48 (17.7%) recurrence and 16 (5.9%) deaths were observed. The risk classification significantly correlated with 3 year disease-free survival and overall survival (log rank p<0.001 and p=0.003, respectively). The survival outcomes of disease-free survival and overall survival were not statistically different among risk groups in patients who received neoadjuvant chemotherapy (log rank p=0.77 and 0.41, respectively). Univariate and multivariable analysis showed that tumor stage (p=0.033, hazard ratio (HR) 2.05, 95% confidence interval (CI) 1.06 to 3.96) was significantly associated with relapse or progression of disease. Patients over age 40 years exhibited a poor prognosis. Conclusion The modified International Germ Cell Cancer Collaborative Group risk classification system was efficacious in patients with malignant ovarian germ cell tumors and was significantly associated with disease-free survival and overall survival. Risk assessment after neoadjuvant chemotherapy may be more predictive than stratification at initial diagnosis. Age and tumor stage were definitive prognostic factors for germ cell tumors, which may need to be incorporated in the stratification system.
引用
收藏
页码:1745 / 1752
页数:8
相关论文
共 50 条
  • [31] Comparison of the clinical features and hematopoietic stem cell transplantation outcomes of mediastinal malignant germ cell tumors with nonmediastinal extragonadal placements
    Ocal, Nesrin
    Yildiz, Birol
    Karadurmus, Nuri
    Dogan, Deniz
    Ozaydin, Sukru
    Ocal, Ramazan
    Ozturk, Mustafa
    Arpaci, Fikret
    Bilgic, Hayati
    ONCOTARGETS AND THERAPY, 2016, 9 : 7445 - 7450
  • [32] Systematic Review of the Survival Outcomes of Neoadjuvant Chemotherapy in Women with Malignant Ovarian Germ Cell Tumors
    Sakaguchi-Mukaida, Hitomi
    Matsuzaki, Shinya
    Ueda, Yutaka
    Matsuzaki, Satoko
    Kakuda, Mamoru
    Lee, Misooja
    Deguchi, Satoki
    Sakata, Mina
    Maeda, Michihide
    Kakubari, Reisa
    Hisa, Tsuyoshi
    Mabuchi, Seiji
    Kamiura, Shoji
    CANCERS, 2023, 15 (18)
  • [33] Clinical review of 55 cases of malignant ovarian germ cell tumors
    Zanagnolo, V
    Sartori, E
    Galleri, G
    Pasinetti, B
    Bianchi, U
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2004, 25 (03) : 315 - 320
  • [34] Reproductive function after treatment of malignant germ cell ovarian tumors
    Sagae, S
    Sasaki, H
    Nishioka, Y
    Terasawa, K
    Kudo, R
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2003, 202 (1-2) : 117 - 121
  • [35] Prognosis of lymphadenectomy in malignant ovarian germ cell tumor
    Lv, Bin
    Liu, Xinghui
    Zheng, Ai
    Han, Ling
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [36] Diagnosis and management of malignant germ cell ovarian tumors in young females
    Zalel, Y
    Piura, B
    Elchalal, U
    Czernobilsky, B
    Antebi, S
    Dgani, R
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1996, 55 (01) : 1 - 10
  • [37] The significance of comprehensive staging surgery in malignant ovarian germ cell tumors
    Liu, Qian
    Ding, Xilai
    Yang, Jiaxin
    Cao, Dongyan
    Shen, Keng
    Lang, Jinghe
    Zhang, Guonan
    Xin, Xiaoyan
    Xie, Xing
    Wu, Yumei
    GYNECOLOGIC ONCOLOGY, 2013, 131 (03) : 551 - 554
  • [38] Survival of metastatic germ cell cancer patients assessed by international germ cell consensus classification in Japan
    Shintaku, Ichiro
    Satoh, Makoto
    Okajima, Eijiro
    Fujimoto, Hiroyuki
    Kamoto, Toshiyuki
    Ogawa, Osamu
    Kawai, Koji
    Akaza, Hideyuki
    Tsukamoto, Taiji
    Naito, Seiji
    Miki, Tsuneharu
    Arai, Yoichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (04) : 281 - 287
  • [39] Malignant ovarian germ cell tumors in adolescents: 18 years of experience at a single institution
    Zhao, Ting
    Liu, Yan
    Zhang, Hao
    Wang, Xiao
    Jiang, Hongyuan
    Lu, Yuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 11934 - 11941
  • [40] Outcomes of men with HIV and germ cell cancer: Results from an international collaborative study
    Hentrich, Marcus Ulrich
    Bower, Mark
    Daugaard, Gedske
    Dieing, Annette
    Bickel, Markus
    Berretta, Massimiliano
    Lesmeister, Florian
    Jurinovic, Vindi
    Stoehr, Albrecht
    Heinzelbecker, Julia
    Krznaric, Ivanka
    Dieckmann, Klaus-Peter
    Necchi, Andrea
    Rey, Pablo Maroto
    Rockstroh, Jurgen Kurt
    Brito, Margarida
    Pfister, David
    Hoffmann, Christian
    CANCER, 2022, 128 (02) : 260 - 268